Hsbc Holdings PLC Fate Therapeutics Inc Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 89,716 shares of FATE stock, worth $148,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,716

Previous 88,514 1.36%

Holding current value

$148,928

Previous $290,000 8.28%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.12 - $5.57 $3,750 - $6,695	1,202 Added 1.36%	89,716 $314,000
Q2 2024 Aug 12, 2024	BUY	$3.26 - $7.08 $73,620 - $159,887	22,583 Added 34.25%	88,514 $290,000
Q1 2024 May 15, 2024	SELL	$3.54 - $8.35 $45,368 - $107,013	-12,816 Reduced 16.27%	65,931 $483,000
Q4 2023 Feb 12, 2024	SELL	$1.65 - $3.94 $52,214 - $124,681	-31,645 Reduced 28.67%	78,747 $294,000
Q3 2023 Nov 13, 2023	BUY	$2.02 - $5.04 $151,578 - $378,196	75,039 Added 212.26%	110,392 $234,000
Q2 2023 Aug 11, 2023	SELL	$4.76 - $6.59 $33,581 - $46,492	-7,055 Reduced 16.64%	35,353 $168,000
Q1 2023 May 15, 2023	SELL	$4.24 - $11.12 $5,893 - $15,456	-1,390 Reduced 3.17%	42,408 $241,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $184,391 - $445,644	18,701 Added 74.51%	43,798 $441,000
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $307,667 - $527,305	14,623 Added 139.61%	25,097 $578,000
Q2 2022 Aug 11, 2022	BUY	$17.78 - $42.39 $37,924 - $90,417	2,133 Added 25.57%	10,474 $258,000
Q1 2022 May 16, 2022	BUY	$29.67 - $60.28 $247,477 - $502,795	8,341 New	8,341 $331,000
Q3 2021 Nov 12, 2021	SELL	$59.27 - $95.73 $250,297 - $404,267	-4,223 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$67.25 - $92.52 $283,996 - $390,711	4,223 New	4,223 $366,000
Q4 2020 Feb 12, 2021	SELL	$38.09 - $100.95 $471,973 - $1.25 Million	-12,391 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$30.41 - $40.5 $105,249 - $140,170	-3,461 Reduced 21.83%	12,391 $502,000
Q2 2020 Aug 14, 2020	BUY	$20.21 - $35.23 $112,630 - $196,336	5,573 Added 54.22%	15,852 $544,000
Q1 2020 May 15, 2020	BUY	$17.28 - $31.88 $177,621 - $327,694	10,279 New	10,279 $233,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $161M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Fate Therapeutics Inc Transaction History